David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.97% |
| 2 | Communication Services | 9.3% |
| 3 | Healthcare | 8.21% |
| 4 | Consumer Discretionary | 8.05% |
| 5 | Energy | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
CSX Corp
CSX
$95.3B
| $1.56M | ﹤0.01% |
162,000
+120,000
| +286% | +$1.11M |
|
|
KKD
2602
PUT
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $1.56M | ﹤0.01% |
88,000
-104,300
| -54% | -$1.93M |
|
|
WAC
2603
PUT
DELISTED
Walter Investment Mgt Corp
WAC
| $1.56M | ﹤0.01% |
+52,200
| New | +$1.57M |
|
|
BTH
2604
DELISTED
BLYTH,INC
BTH
| $1.55M | ﹤0.01% |
144,586
+42,122
| +41% | +$412K |
|
2605
CALL
Nike
NKE
$57B
| $1.55M | ﹤0.01% |
42,000
+2,000
| +5% | +$75.6K |
|
2606
White Mountains Insurance
WTM
$5.09B
| $1.55M | ﹤0.01% |
2,577
-3,040
| -54% | -$1.77M |
|
|
DF
2607
DELISTED
Dean Foods Company
DF
| $1.54M | ﹤0.01% |
99,911
-456,533
| -82% | -$7.11M |
|
|
TSYS
2608
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $1.54M | ﹤0.01% |
670,958
-113,560
| -14% | -$258K |
|
2609
HCI Group
HCI
$2.33B
| $1.54M | ﹤0.01% |
42,303
+25,295
| +149% | +$1.11M |
|
2610
CALL
NetApp
NTAP
$37.2B
| $1.54M | ﹤0.01% |
41,700
+1,700
| +4% | +$68.7K |
|
|
NTUS
2611
DELISTED
Natus Medical Inc
NTUS
| $1.54M | ﹤0.01% |
59,654
-16,597
| -22% | -$418K |
|
2612
PUT
Green Plains
GPRE
$1B
| $1.54M | ﹤0.01% |
+51,300
| New | +$1.26M |
|
2613
MaxLinear
MXL
$5.77B
| $1.54M | ﹤0.01% |
162,129
+16,313
| +11% | +$163K |
|
|
GDP
2614
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $1.53M | ﹤0.01% |
97,022
-41,692
| -30% | -$647K |
|
2615
CALL
Popular Inc
BPOP
$10.8B
| $1.53M | ﹤0.01% |
49,500
-200
| -0.4% | -$5.69K |
|
2616
CALL
Southern Company
SO
$102B
| $1.53M | ﹤0.01% |
34,900
-10,000
| -22% | -$419K |
|
2617
Acadia Pharmaceuticals
ACAD
$5.1B
| $1.53M | ﹤0.01% |
62,964
-7,753
| -11% | -$196K |
|
2618
Bank OZK
OZK
$5.39B
| $1.53M | ﹤0.01% |
45,020
+33,272
| +283% | +$1.03M |
|
|
PRXL
2619
PUT
DELISTED
Parexel International Corp
PRXL
| $1.53M | ﹤0.01% |
28,300
-6,700
| -19% | -$343K |
|
|
HBI
2620
PUT
DELISTED
Hanesbrands
HBI
| $1.53M | ﹤0.01% |
80,000
-310,000
| -79% | -$5.56M |
|
2621
Movado Group
MOV
$765M
| $1.53M | ﹤0.01% |
33,563
+3,625
| +12% | +$148K |
|
2622
PUT
Open Text
OTEX
$6.07B
| $1.53M | ﹤0.01% |
+64,000
| New | +$1.55M |
|
2623
Gerdau
GGB
$9.1B
| $1.52M | ﹤0.01% |
299,852
+9,883
| +3% | +$52.4K |
|
2624
PUT
Standard BioTools
LAB
$252M
| $1.52M | ﹤0.01% |
+34,600
| New | +$1.52M |
|
2625
Artivion
AORT
$1.3B
| $1.52M | ﹤0.01% |
152,792
-21,243
| -12% | -$218K |
|
Similar funds
David Shaw's Q1 2014 Portfolio in Review
As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw deployed $3.3B of net new capital in Q1 2014, opening 596 new positions and adding to 1,359 existing holdings. Its largest new stake was Veren: 1,596,878 shares worth $53.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 44% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $453M trimmed.
- David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- David Shaw opened 596 new positions and closed 795 in Q1 2014.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.